What is Tectonic Therapeutics's tax expense (benefit)?

Tectonic Therapeutics (TECX) reported tax expense (benefit) of $25.2M in Q1 2026.

How has Tectonic Therapeutics's tax expense (benefit) changed year-over-year?

Tectonic Therapeutics's tax expense (benefit) increased by 58.4% year-over-year, from $15.91M to $25.2M.

What is the long-term trend for Tectonic Therapeutics's tax expense (benefit)?

Over 2 years (2023 to 2025), Tectonic Therapeutics's tax expense (benefit) has grown at a 31.7% compound annual growth rate (CAGR), from $42.83M to $74.26M.

Tectonic Therapeutics TECX Tax expense (benefit)

Tax expense (benefit) at other companies

Capital City Bank GroupCCBG

-$791K-166%

Cal-Maine FoodsCALM

$25K-49.0%

CEP

Cantor Equity Partners II, Inc. Class A Ordinary ShareCEPT

-$115.76K—

Minerals TechnologiesMTX

$750K-70.3%

PNC Financial ServicesPNC

-$117M-128%

Hanmi FinancialHAFC

$896K+121%

Other financials

Income statement

See full

Operating income-$27.3M-49.2%

Net income-$25.2M-58.7%

EPS (diluted)-$1.34-44.1%

Balance sheet

See full

Cash & equivalents$236.9M-22.8%

Total debt$4.9M+86.1%

Total equity$230.4M-23.5%

Total assets$246.6M-21.7%

Cash flow

See full

Operating cash flow-$18.4M-40.7%

CapEx$19.0K-29.6%

Free cash flow-$18.4M-40.6%

Valuation

See full

Market cap$585.51M+58.3%

Enterprise value$353.51M+438%

Returns & leverage

See full

Return on equity-31.4%—

Debt / equity0×0.0×

Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossTax.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's tax expense (benefit).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tectonic Therapeutics's tax expense (benefit)?: Tectonic Therapeutics (TECX) reported tax expense (benefit) of $25.2M in Q1 2026.
How has Tectonic Therapeutics's tax expense (benefit) changed year-over-year?: Tectonic Therapeutics's tax expense (benefit) increased by 58.4% year-over-year, from $15.91M to $25.2M.
What is the long-term trend for Tectonic Therapeutics's tax expense (benefit)?: Over 2 years (2023 to 2025), Tectonic Therapeutics's tax expense (benefit) has grown at a 31.7% compound annual growth rate (CAGR), from $42.83M to $74.26M.